Medical and Pharmaceutical Galleri shows promise in large U.S. based clinical trial Researchers believe this approach could allow doctors to catch cancers much earlier Joseph MortonOctober 20, 2025
Medical and Pharmaceutical Evaxion shares spike as AI-designed melanoma vaccine data hits market The presentation will include information on the breadth, magnitude, and duration of T-cell responses following booster immunization Joseph MortonOctober 15, 2025
Medical and Pharmaceutical Inovio advances DNA medicine for debilitating respiratory condition The FDA acknowledged that the therapy could support a Biologics License Application under its accelerated approval program Joseph MortonAugust 28, 2025
Crypto/Blockchain 180 Life Sciences shares spike 76% on crypto company rebrand The company committed to building a substantial Ethereum treasury Joseph MortonAugust 12, 2025
Medical and Pharmaceutical Puma Biotechnology shares get favourable price bump on strong Q2 results The absence of negative developments over the past month has helped sentiment recover Joseph MortonAugust 11, 2025
Medical and Pharmaceutical Y-mAbs stock soars over 100% after acquisition deal with SERB S.A.S. The stock opened at USD$8.54 and traded as high as USD$8.59 before dipping briefly to USD$4.20 before ending the day at USD$8.52 Joseph MortonAugust 5, 2025
Medical and Pharmaceutical Lantern Pharma completes Japanese enrolment for lung cancer drug trial Japan has an extremely high rate of non-smokers getting diagnosed with the disease Rowan DunneAugust 5, 2025
Crypto/Blockchain Liminatus Pharma shares spike 26% on Digital Asset focused capital raise plans The engagement builds upon Liminatus’s previously announced review of a blockchain-integrated treasury strategy Joseph MortonJuly 24, 2025
Medical and Pharmaceutical Cizzle Bio submits NIH grant proposal for biomarker blood test for lung cancer The study will analyze pre-diagnostic and longitudinal blood plasma samples from the PLCO Cancer Screening Trial Joseph MortonJuly 14, 2025
Medical and Pharmaceutical Supernus Pharmaceuticals picks up embattled Sage Therapeutics Acquiring Sage expands Supernus’s presence in nonpsychiatric conditions Joseph MortonJune 16, 2025